• Farmacosmo posted 2Q 2026 group revenue of EUR 9.9 million, up 19% from EUR 8.4 million in 1Q 2026.
• 1H 2026 group revenue fell 10% to EUR 18.4 million from EUR 20.4 million a year earlier, reflecting a higher gross margin focus.
• Retail platforms delivered EUR 18.4 million in 1H revenue versus EUR 20 million; 2Q retail revenue rose 19% versus 1Q.
• ContactU 1H revenue rose 14% to over EUR 450,000; therapies reached about 10,000 versus 8,500 a year earlier.
• ProfumeriaWeb 1H revenue increased 18% to more than EUR 2 million; pharma revenue slipped 13% to about EUR 16 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Farmacosmo S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 20253-25-2026_TELEBORSA.pdf), on July 30, 2026, and is solely responsible for the information contained therein.